Albert E. Doro
Pfizer
1 Papers
22 Citations
Albert E. Doro is an academic researcher from Pfizer. The author has contributed to research in topics: Bioconversion & Pseudomonas putida. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Biocatalytic Oxidation of 2-Methylquinoxaline to 2-Quinoxalinecarboxylic Acid
John W. Wong,Watson Harry A,James F. Bouressa,Michael Paul Burns,Cawley James Joseph,Albert E. Doro,Donald B. Guzek,Michael A. Hintz,Ellen L. McCormick,Douglas Alan Scully,Joseph M. Siderewicz,William J. Taylor,and Susan J. Truesdell,Richard Gerald Wax +13 more
TL;DR: Although successfully scaled to produce kilograms of 2-quinoxalinecarboxylic acid for synthesis of a drug candidate, the A. repens bioconversion is unsuitable for further scale-up due to low product concentration (∼1 g/L).
22